Dr. Li Chen
Director of Biologics Discovery at GenScript ProBio
BS of Bioinformatics from Zhejiang University of China; PhD training of immunology from University of Massachusetts Medical School. After joining GenScript, Dr. Chen is in charge of the antibody drug discovery services, and has more than 10 years’ experience in immunology, antibody drug discovery and engineering, managing over 300 antibody drug discovery/engineering projects.
Title: Fully human antibody discovery strategy
- Transgenic animal is the most popular approach to get fully human antibody
- The 3 platforms GenScript ProBio collaborating with are outstanding in diversity and humanization design
- Case studies show that the 3 platforms share good immune response and antibody discovery feasibility